PMINJ 2020 April Meeting

Abstract

Join us for a vibrant discussion of the crucial role that a PMO can play in the launch of new products in the Pharma industry! Presentation to be led by experts with experience in over 14 pharma product launches

Key topics

The PMO in Pharma: What is the recipe for successfully building the PMO? What should be a typical PMO structure? How to find the right talent?
New Product Launches in Pharma: How can the PMO be an enabler? What are the secrets of success? What are the pitfalls?
Agile in Pharma: Does Agile have a place for team collaboration in this environment? Can Agile be used successfully for monitoring and reporting progress?

Discussion will include a case study on Agile implementation and some early results.

Speakers

Bios:
Divya T Yerraguntla - Sr. Director/Head Global Commercial Program Management Office - SUN Pharmaceuticals Industries, Inc.

An established leader in Marketing, Launch Planning and Strategy for Pharmaceutical industry, Divya has been in the industry for more than 20 years working with companies such as Capgemini, Johnson & Johnson, Novo Nordisk and SUN pharma. She is a seasoned Speaker and Chairperson on various Pharma Forums and conferences.

She has extensive experience in Strategy development and Pharmaceutical product launches in Diabetes, Obesity, Oncology, Dermatology, Biologics and Ophthalmology. With more than 20 product launches she has a passion for operational aspects of mission critical projects that maximize portfolio and have a positive impact on patient lives.

Srinivasan Sriram - Senior Program Manager - Global Commercial Program Management Office - Sun Pharmaceuticals Industries Inc.

Patient & team centric, selfless program leader with 15+ years of robust CMC & Drug-Device Product development experience in both biologics & small molecules.
Championed 3+ branded product launches & 5+ Clinical trials, NDA & IND submissions across Respiratory, Ophthalmology, Hyperlipidemia & Dermatology therapeutic areas.
Worked & Partnered with leading pharma companies like J&J, Teva, Novartis, BMS, Gilead, Sun Pharma & Merck

21 Apr 2020 - Virtual

PDP Information

Abstract

Speakers

Other Meetings - None:

Photos - None